Cortigent Orion Visual Cortical Prosthesis completes six-year feasibility study

Cortigent (Vivani Medical subsidiary)/Orion Visual Cortical Prosthesis

Cortigent presented results from a six-year Early Feasibility Study of the Orion Visual Cortical Prosthesis at the North American Neuromodulation Society annual meeting in January 2026. Six subjects implanted between 2018 and 2019 showed improvement with the system on versus off in visual function tests. All devices remained operational with fewer than 4% of electrodes losing functionality over the six-year period.

• Six subjects implanted 2018-2019 completed study in March 2025 after six years of follow-up.
• All six subjects demonstrated improvement in detecting a small square on a computer screen and detecting motion across the visual field when the system was activated.
• Device reliability was high: 96% of electrodes remained functional at study conclusion.
• Next step is planning a larger pivotal clinical trial to seek FDA marketing approval.